Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.
Copyright © 2015 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Adapted from Myers et al. [24], with permission from Springer.
Immunoreactive structure | Target (antibody) |
---|---|
Axons | Protein gene product 9.5 (anti-PGP 9.5) |
Compact myelin | Myelin basic protein (anti-MBP) |
Basement membrane, blood vessels | Collagen type IV (anti-Col IV) |
Autonomic cholinergic fibers | Vasoactive intestinal peptide (anti-VIP) |
Autonomic adrenergic fibers | Dopamine β hydroxylase (anti-DβH), tyrosine hydroxylase (anti-TH) |
Peptidergic sensory C fibers | Substance P (anti-SP), calcitonin gene related peptide (anti-CGRP) |
Schwann cells | S100 protein (anti-S100), low affinity nerve growth factor receptor (anti-p75) |
Large diameter myelinated fibers | Neurofilaments (anti-NF) |
Adapted from Myers et al. [